Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Crispr Therapeutics Ag
(NQ:
CRSP
)
54.01
-1.37 (-2.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
27
28
Next >
Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock
June 07, 2023
Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock.
Via
InvestorPlace
Why Are Gene Editing Stocks EDIT, NVTA, CRSP Up Today?
June 06, 2023
Gene editing stocks are up today on news that Editas Medicine will present clinical data on June 12. Here's what this means for the sector.
Via
InvestorPlace
3 Top Healthcare Stocks to Buy for June
June 06, 2023
These stocks have what it takes to deliver long-term growth.
Via
The Motley Fool
CRISPR Therapeutics: A Galaxy's Worth of Deep Value
May 31, 2023
Wall Street is at max pessimism with this biotech, which might be a big mistake.
Via
The Motley Fool
3 Disruptors I Love Right Now
May 30, 2023
These stocks could deliver huge returns as the companies transform the economy.
Via
The Motley Fool
Prediction: These 2 Stocks Could Double In the Next Year
May 28, 2023
It would be a continuation of solid recent performances.
Via
The Motley Fool
CRISPR Therapeutics Earnings Perspective: Return On Capital Employed
May 23, 2023
Via
Benzinga
Analyst Expectations for CRISPR Therapeutics's Future
May 23, 2023
Via
Benzinga
Is CRISPR Therapeutics Stock a Buy Now?
May 13, 2023
The clinical-stage biotech company has been on the rise.
Via
The Motley Fool
Is It Too Late to Buy CRISPR Stock?
April 27, 2023
Five reasons to buy the promising biotech stock now.
Via
The Motley Fool
3 No-Brainer Stocks to Buy for Under $100 Right Now
May 27, 2023
These stocks might not remain under $100 for too much longer.
Via
The Motley Fool
2 Supercharged Stocks to Buy With $100
May 27, 2023
These stocks are climbing in the double digits.
Via
The Motley Fool
2 Top Trends to Invest $5,000 in Right Now
May 25, 2023
Renewable energy and gene-editing medical therapies are poised to grow exponentially.
Via
The Motley Fool
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health
May 25, 2023
Both stocks are recovering after big losses last year.
Via
The Motley Fool
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
Cathie Wood Just Sold CRISPR Therapeutics Stock. Here's Why You Should Consider Buying It
May 21, 2023
Her investing thesis for holding it is probably the same as ever.
Via
The Motley Fool
Cathie Wood Is Buying This Biotech Stock Like Wildfire, But Should You?
May 21, 2023
It's facing a few issues that are practically guaranteed to affect shareholder returns.
Via
The Motley Fool
3 Biotech Stocks That Are Revolutionizing Healthcare in 2023
May 19, 2023
Here are three of the best biotech stocks to buy; each is on the verge of significant breakthroughs that may send the price higher.
Via
InvestorPlace
Vertex Pharmaceuticals Hits Record High on Strong Q1 Earnings
May 18, 2023
Vertex Pharmaceuticals hits record high on strong earnings, FDA approval for cystic fibrosis medication for infants. Analysts recently boosted price targets.
Via
MarketBeat
Exposures
Product Safety
2 Stocks You'll Be Glad You Bought at These Prices
May 17, 2023
Bear markets create opportunities to buy high-growth stocks at discounted valuations.
Via
The Motley Fool
2 Soaring Growth Stocks That Could Rocket Even Higher
May 16, 2023
One of these stocks is up 57% this year, and the other one has more than tripled already.
Via
The Motley Fool
Why These 3 Nasdaq Stocks Were Glowing Green This Week
May 11, 2023
These three biopharmaceutical stocks rocketed higher this week.
Via
The Motley Fool
Devon Energy, CRISPR Therapeutics, And Bullish On Berkshire Succession: CNBC's 'Final Trades'
May 10, 2023
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said CRISPR Therapeutics AG (NASDAQ: CRSP) reported strong
Via
Benzinga
Why CRISPR Therapeutics Stock Is on Fire Today
May 09, 2023
Thanks to the gene-editing pioneer having a pipeline chock-full of deep value and a possible regulatory approval on tap, investors are bidding up shares today.
Via
The Motley Fool
Something Happened In Biotech Last Week
May 08, 2023
Biotech stocks were more constructive last week with some sharp moves up.
Via
Talk Markets
This Incredible Growth Stock Has All the Hallmarks of a Prototypical Warren Buffett Stock
May 06, 2023
Vertex Pharmaceuticals faces limited competition in its core area of expertise, has a top-shelf CEO, and is building out a profoundly valuable pipeline of next-generation assets.
Via
The Motley Fool
1 Incredibly Undervalued Growth Stock to Buy Hand Over Fist in May
May 04, 2023
This market-beating biotech stock still has more room to run.
Via
The Motley Fool
3 Top Healthcare Stocks to Buy in May
May 04, 2023
You'll want to hold onto these innovative companies for the long term.
Via
The Motley Fool
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
May 02, 2023
Cathie Wood is loading up on these biotech stocks.
Via
The Motley Fool
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
27
28
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.